Dare Bioscience, Inc.
DARE· Nasdaq
DAREDare Bioscience, Inc.
Filed Mar 19, 2015 · 10-K · 78 days after period end · 0001564590-15-001834
| Metric | Q4 2014 | Q4 2013 |
|---|---|---|
| Revenue | $0.00 | $6.00K |
| Net Income | -$7.47M | -$3.48M |
| EPS Diluted | -$0.37 | -$4.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Mar 19, 2015 · 78 d after period end
